AI tools for cancer immunotherapy face safety and ethical hurdles before routine use

Cancer patients rely on treatments that boost their own immune systems to fight disease. Researchers reviewed how artificial intelligence might help doctors choose the best immunotherapy options. These smart tools could analyze complex data to find patterns humans might miss. The goal is to make life-saving treatments more effective for people with cancer. However, the review highlights serious concerns that must be solved first. Data quality control remains a major worry. If the information fed into these systems is flawed, the results could be wrong. Patient safety is another critical issue. Ethical dilemmas also arise when algorithms make decisions about care. These obstacles have already prevented AI from becoming part of daily clinical practice. Until these problems are fixed, doctors cannot trust these tools to guide treatment choices. The technology is promising, but the path to real-world use is blocked by significant challenges.